Tenax Therapeutics TENX
NASDAQ TENX
$1.88 0.00 (-0.26%)
As of: Oct 1, 2026 · 10:45 AM EDT

Tenax Therapeutics (TENX) Finished Goods (2012 - 2014)

Updated

Tenax Therapeutics' Finished Goods was $68,658 in Q3 2014, down 13.3% from $79,159 a year earlier and down 0.8% from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Finished Goods (2012 - 2014) Analysis & Trends

At the end of FY2013, Finished Goods at Tenax Therapeutics came in at $70,425, up 21.9% from FY2012.

  • In earlier years, Finished Goods was $57,791 in FY2012.
  • The Q3 2014 figure marks the lowest quarterly Finished Goods since Q1 2013.
  • Compared with a year earlier, Finished Goods was higher in two of the last four quarters, with growth averaging 9.1%.
  • Per Business Quant data, TENX's Finished Goods in the three quarters before Q3 2014 was $69,206 (Q2 2014), $70,157 (Q1 2014) and $70,425 (Q4 2013).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tenax Therapeutics 85.48 Mn 85.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2014 68,658.00
Oct 31, 2013 69,206.00
Jul 31, 2013 70,157.00
Apr 30, 2013 70,425.00
Jan 31, 2013 79,159.00
Oct 31, 2012 80,578.00
Jul 31, 2012 49,480.00
Apr 30, 2012 57,791.00
API Access

Tenax Therapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=TENX&period=max&api_key=YOUR_API_KEY